| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.04 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.04 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.04 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.079 | 0.04 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.04 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.079 | 0.04 |